Jason M. Mehal

Jason M. Mehal

Auto-generated profile, based on publicly available information

Jason M. Mehal

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS), Atlanta, GA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2013 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Verified
Journal Article
Closed access
JMJason M. Mehal
Jason M. Mehal
RHRobert C. Holman
Robert C. Holman
LSLawrence B. Schonberger
Lawrence B. Schonberger
JSJames J. Sejvar
James J. Sejvar
Our objective was to examine trends and epidemiology of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) associated deaths in the United States. ALS/MND associated death rates and trends in the United States for 1999–2009 were examined using the multiple cause-of-death mortality data. Age-specific and age-adjusted death rates were calculated. For 1999–2009, the average annual age-adjusted death rate was 2.17/100,000 persons. The age-specific rate increased with age until 75–79 years. Males experienced a higher death rate than females. There was no definitive trend in the annual ALS/MND associated death rate, although analyses suggested a possible decrease (p = 0.05); however, the rate increased for persons 20–49 years of age and declined for persons ≥ 65 years of age. The annual rate for males decreased whereas the rate for females showed no change. In conclusion, the suggested decreasing annual ALS/MND associated death rate for 1999–2009 contrasts with earlier reports indicating that the incidence and death rate of ALS were increasing. While the ALS/MND associated death rate slightly increased among adults 20–49 years of age, rates declined among two subpopulations at higher risk for ALS/MND – males and persons ≥ 65 years of age. Continued monitoring of ALS/MND mortality data and additional epidemiological studies will be important to further elucidate these epidemiological trends.

1 July 2012 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
JMJason M. Mehal
Jason M. Mehal
DEDouglas H. Esposito
Douglas H. Esposito
RHRobert C. Holman
Robert C. Holman
JTJacqueline Tate
Jacqueline Tate
LCLaura S. Callinan
Laura S. Callinan
UPUmesh D. Mb Bs Parashar
Umesh D. Mb Bs Parashar
Background: Diarrhea-associated deaths among US children increased from the mid-1980s through 2006, particularly among infants. Understanding risk factors for diarrhea-associated death could improve prevention strategies. Methods: Records of singleton infants with diarrhea listed anywhere on the death certificate were selected from the US Linked Birth/Infant Death data for the period, 2005 to 2007; characteristics of these infants were compared with those of infants who survived their first year. Results: During 2005 to 2007, 1087 diarrhea-associated infant deaths were reported; 86% occurred among low birth weight (LBW, <2500 g) infants. Compared with normal birth weight (NBW, ≥2500 g) infants, LBW infants had a greater mortality rate (risk ratio: 91.9, 95% confidence interval: 77.4–109.0) and younger median age at death (7 versus 15 weeks, P < 0.0001). The most common codiagnoses for diarrhea-associated death among LBW and NBW infants were sepsis (26%) and volume depletion (20%), respectively. Among LBW infants, 97% of diarrhea-associated deaths occurred in inpatient settings, whereas 27% of NBW infant deaths occurred in outpatient settings and 5.3% in the decedent’s home. Male sex, black race, unmarried status and low 5-minute Apgar score (<7) increased mortality odds among LBW infants whereas, among NBW infants, low 5-minute Apgar score, black race, young maternal age (<25 years) and high birth order (third or more) increased mortality odds. Conclusions: Efforts to reduce diarrhea-associated morality should focus on understanding and improving management of diarrhea in vulnerable LBW infants. For prevention of diarrhea-associated deaths in NBW infants, educating mothers who fit the high-risk profile regarding home hydration therapy and timely access to medical treatment is important.

1 September 2014 in Chest
Verified
Journal Article
Closed access
JMJason M. Mehal
Jason M. Mehal
RHRobert C. Holman
Robert C. Holman
CSClaudia A. Steiner
Claudia A. Steiner
MBMichael L. Bartholomew
Michael L. Bartholomew
RSRosalyn J. Singleton
Rosalyn J. Singleton

5 February 2014 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
JMJason M. Mehal
Jason M. Mehal
RHRobert C. Holman
Robert C. Holman
DBDanny A. Brass
Danny A. Brass
JBJesse D. Blanton
Jesse D. Blanton
BPBrett W. Petersen
Brett W. Petersen
The purpose of the study was to evaluate changes in the knowledge of bat rabies and human exposure among United States cavers during the last decade. A survey was distributed among cavers who attended the National Speleological Society convention in 2000 and those who attended in 2010. In 2000 and 2010, 392 and 108 cavers, respectively, responded to the questionnaire. Eighty-five per cent of respondents in 2000 indicated a bat bite as a risk for rabies compared with all respondents in 2010 (P < 0.0001 controlling for age). The proportion of respondents indicating that they were advised to receive rabies pre-exposure prophylaxis (PreEP) because of caving increased (17% and 29%; P = 0.03 controlling for age). Among these, PreEP was received by 56% and 45%. Although recognition of the risk of rabies exposure from bats is important, the proportion of cavers acting on current recommendations regarding PreEP does not appear to have improved in the past decade.

2 April 2014 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
JMJason M. Mehal
Jason M. Mehal
RHRobert C. Holman
Robert C. Holman
NVNeil M. Vora
Neil M. Vora
JBJesse Blanton
Jesse Blanton
PGPaul H. Gordon
Paul H. Gordon
JCJames E. Cheek
James E. Cheek
Reliable laboratory testing is of great importance to detect Bartonella bacilliformis infection. We evaluated the sensitivity and specificity of the enzyme-linked immunosorbent assay (ELISA) using recombinant protein Pap31 (rPap31) for the detection of antibodies against B. bacilliformis as compared with immunofluorescent assay (IFA). Of the 302 sera collected between 1997 and 2000 among an at-risk Peruvian population, 103 and 34 samples tested positive for IFA-immunoglobulin G (IgG) and IFA-IgM, respectively. By using Youden's index, the cutoff values of ELISA-IgG at 0.915 gave a sensitivity of 84.5% and specificity of 94%. The cutoff values of ELISA-IgM at 0.634 gave a sensitivity of 88.2% and specificity of 85.1%. Using latent class analysis, estimates of sensitivity and specificity of almost all the assays were slightly higher than those of a conventional method of calculation. The test is proved beneficial for discriminating between infected and non-infected individuals with the advantage of low-cost and high-throughput capability.